Barclays PLC Abbott Laboratories Transaction History

Barclays PLC

$288 Billion
Q1 2024

A detailed history of Barclays PLC transactions in Abbott Laboratories stock. As of the latest transaction made, Barclays PLC holds 48,000 shares of ABT stock, worth $4.91 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

48,000

Previous 2,779,125 98.27%

Holding current value

$4.91 Million

Previous $306 Million 98.22%

% of portfolio

0.0%

Previous 0.11%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$109.52 - $120.96 $22.1 Million - $24.4 Million	201,630 Added 7.26%	2,980,755 $339 Million
Q4 2023 Feb 15, 2024	SELL	$90.19 - $110.4 $45.8 Million - $56.1 Million	-507,887 Reduced 15.45%	2,779,125 $306 Million
Q3 2023 Nov 07, 2023	BUY	$95.53 - $114.62 $7.84 Million - $9.41 Million	82,098 Added 2.56%	3,287,012 $318 Million
Q2 2023 Aug 03, 2023	BUY	$100.78 - $112.29 $191 Million - $213 Million	1,898,517 Added 145.32%	3,204,914 $349 Million
Q1 2023 May 04, 2023	SELL	$96.86 - $114.01 $123 Million - $144 Million	-1,266,971 Reduced 49.23%	1,306,397 $132 Million

Q4 2022 Feb 13, 2023	BUY	$95.06 - $111.52 $45.1 Million - $53 Million	474,944 Added 22.63%	2,573,368 $283 Million
Q3 2022 Nov 03, 2022	BUY	$96.76 - $112.03 $31.7 Million - $36.7 Million	327,513 Added 18.49%	2,098,424 $203 Million
Q2 2022 Aug 12, 2022	SELL	$102.07 - $123.37 $80.4 Million - $97.2 Million	-787,765 Reduced 30.79%	1,770,911 $192 Million
Q1 2022 May 16, 2022	SELL	$114.02 - $139.04 $159 Million - $194 Million	-1,397,299 Reduced 35.32%	2,558,676 $303 Million
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $84.9 Million - $104 Million	735,104 Added 22.82%	3,955,975 $557 Million
Q3 2021 Nov 09, 2021	BUY	$116.66 - $129.06 $74 Million - $81.9 Million	634,747 Added 24.54%	3,220,871 $380 Million
Q2 2021 Aug 13, 2021	BUY	$105.79 - $124.53 $74.7 Million - $87.9 Million	706,110 Added 37.56%	2,586,124 $300 Million
Q1 2021 May 13, 2021	SELL	$108.84 - $128.23 $16 Million - $18.9 Million	-147,068 Reduced 7.26%	1,880,014 $225 Million
Q4 2020 Feb 11, 2021	SELL	$105.0 - $114.42 $69.6 Million - $75.8 Million	-662,683 Reduced 24.64%	2,027,082 $222 Million
Q3 2020 Nov 12, 2020	BUY	$91.64 - $111.29 $108 Million - $131 Million	1,181,403 Added 78.32%	2,689,765 $293 Million
Q2 2020 Aug 12, 2020	BUY	$76.57 - $98.0 $31.7 Million - $40.5 Million	413,605 Added 37.78%	1,508,362 $138 Million
Q1 2020 May 13, 2020	SELL	$62.82 - $91.86 $122 Million - $178 Million	-1,937,034 Reduced 63.89%	1,094,757 $86.4 Million
Q4 2019 Feb 10, 2020	BUY	$78.51 - $87.4 $59.4 Million - $66.1 Million	756,272 Added 33.24%	3,031,791 $263 Million
Q3 2019 Nov 14, 2019	SELL	$81.84 - $88.74 $37.3 Million - $40.5 Million	-456,121 Reduced 16.7%	2,275,519 $190 Million
Q2 2019 Aug 14, 2019	BUY	$72.88 - $85.0 $31 Million - $36.2 Million	425,400 Added 18.45%	2,731,640 $230 Million
Q1 2019 May 15, 2019	BUY	$66.22 - $80.06 $10.2 Million - $12.4 Million	154,745 Added 7.19%	2,306,240 $184 Million
Q4 2018 Feb 14, 2019	SELL	$65.56 - $74.27 $44.8 Million - $50.8 Million	-684,102 Reduced 24.13%	2,151,495 $156 Million
Q3 2018 Nov 14, 2018	BUY	$60.81 - $73.36 $49.2 Million - $59.4 Million	809,519 Added 39.95%	2,835,597 $208 Million
Q2 2018 Aug 14, 2018	SELL	$57.57 - $63.54 $60.7 Million - $67 Million	-1,054,636 Reduced 34.23%	2,026,078 $124 Million
Q1 2018 May 15, 2018	BUY	$56.27 - $63.62 $54.3 Million - $61.4 Million	964,434 Added 45.57%	3,080,714 $185 Million
Q4 2017 Feb 14, 2018	BUY	$53.68 - $57.47 $64.1 Million - $68.6 Million	1,194,493 Added 129.58%	2,116,280 $121 Million
Q3 2017 Nov 14, 2017	BUY	$48.06 - $53.64 $44.3 Million - $49.4 Million	921,787	921,787 $49.2 Million

Others Institutions Holding ABT

# of Institutions

3,124

Shares Held

1.29B

Call Options Held

8.43M

Put Options Held

8.71M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $179B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account